Antiarrhythmic Drug Combinations in the Treatment of Ventricular Tachycardia

Circulation - United States
doi 10.1161/01.cir.66.6.1205
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Cost Effectiveness of Ventricular Tachycardia Ablation Versus Escalation of Antiarrhythmic Drug Therapy in the Vanish Trial

Canadian Journal of Cardiology
Cardiovascular MedicineCardiology
2017English

Antiarrhythmic Effects of the Class 1c Antiarrhythmic Drug, Flecainide, on Canine Ventricular Arrhythmia Models.

Japanese Heart Journal
1989English

Network Meta-Analysis on the Efficacy of Antiarrhythmic Drugs for the Termination of Ventricular Tachycardia

Canadian Journal of Cardiology
Cardiovascular MedicineCardiology
2018English

Wide Complex Tachycardia – Ventricular Tachycardia or Not Ventricular Tachycardia, That Remains the Question

Arrhythmia and Electrophysiology Review
Cardiovascular MedicinePhysiologyCardiology
2013English

Ventricular Tachycardia

Journal of Arrhythmia
Cardiovascular MedicineCardiology
2019English

Antiarrhythmic Drug Therapy for Atrial Fibrillation in Patients With Left Ventricular Dysfunction

Japanese Journal of Electrocardiology
2014English

Coronary Venous Ethanol Infusion for the Treatment of Refractory Ventricular Tachycardia

Heart Rhythm
Cardiovascular MedicinePhysiologyCardiology
2012English

Combined Mexiletine and Propranolol Treatment of Refractory Ventricular Tachycardia.

BMJ
1980English

Inhibition of Cardiac Ca2+ Release Channels (RyR2) Determines Efficacy of Class I Antiarrhythmic Drugs in Catecholaminergic Polymorphic Ventricular Tachycardia

Circulation: Arrhythmia and Electrophysiology
MedicineCardiovascular MedicinePhysiologyCardiology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy